The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Association of Transcription Factor APRF and Protein Kinase Jak1 with the Interleukin-6 Signal Transducer gp130
Abstract
Interleukin-6 (IL-6), leukemia inhibitory factor, oncostatin M, interleukin-11, and ciliary neurotrophic factor bind to receptor complexes that share the signal transducer gp130. Upon binding, the ligands rapidly activate DNA binding of acute-phase response factor (APRF), a protein antigenically related to the p91 subunit of the interferon-stimulated gene factor-3α (ISGF-3α). These cytokines caused tyrosine phosphorylation of APRF and ISGF-3α p91. Protein kinases of the Jak family were also rapidly tyrosine phosphorylated, and both APRF and Jak1 associated with gp130. These data indicate that Jak family protein kinases may participate in IL-6 signaling and that APRF may be activated in a complex with gp130.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both IFN␥ and IL-6 can activate JAK1 (4 -6) and JAK2 (7-10), and subsequently STAT1 (11,12) and STAT3 (6,13,14).”
From The Comparative Roles of Suppressor of Cytokine Signaling-1 and -3 in the Inhibition and Desensitization of Cytokine Signaling (2006) · cites this paper as [6]
Citations
Cites
Kessler, D. S., Veals, S. A., Fu, X. Y., & Levy, D. E. (1990) · Genes & Development · doi:10.1101/gad.4.10.1753 · Cited by 312
Flagged first, then by citations
Research works printed but not linked: 30
- 10.1016/0092-8674(93)90415-M · DOI
- BAZAN, J.F., NEUROPOIETIC CYTOKINES IN THE HEMATOPOIETIC FOLD, NEURON 7: 197 (1991). · DOI
- BAZAN, J.F., STRUCTURAL DESIGN AND MOLECULAR EVOLUTION OF A CYTOKINE RECEPTOR SUPERFAMILY, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 87: 6934 (1990).
- COOPER, J.A., DETECTION AND QUANTIFICATION OF PHOSPHOTYROSINE IN PROTEINS, METHODS IN ENZYMOLOGY 99: 387 (1983). · DOI
- 10.1126/science.8390097 · DOI
- DECKER, T, CYTOPLASMIC ACTIVATION OF GAF, AN IFN-GAMMA-REGULATED DNA-BINDING FACTOR, EMBO JOURNAL 10: 927 (1991). · DOI
- FIRMBACHKRAFT, I, TYK2, PROTOTYPE OF A NOVEL CLASS OF NONRECEPTOR TYROSINE KINASE GENES, ONCOGENE 5: 1329 (1990).
- FU, X.Y., TRANSCRIPTION FACTOR P91 INTERACTS WITH THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND MEDIATES ACTIVATION OF THE C-FOS GENE PROMOTER, CELL 74: 1135 (1993). · DOI
- 10.1126/science.1542794 · DOI
- HIBI, M, MOLECULAR-CLONING AND EXPRESSION OF AN IL-6 SIGNAL TRANSDUCER, GP130, CELL 63: 1149 (1990). · DOI · Paper page
- Hibi, M., Cell 63: 1149 (1990). · DOI · Paper page
- 10.1126/science.8378773 · DOI
- 10.1126/science.8511589 · DOI
- PATTERSON, P.H., NEURONAL DIFFERENTIATION FACTORS CYTOKINES AND SYNAPTIC PLASTICITY, CELL 72: 123 (1993). · DOI
- PELLEGRINI, S, EARLY EVENTS IN SIGNALING BY INTERFERONS, TRENDS IN BIOCHEMICAL SCIENCES 18: 338 (1993). · DOI
- 10.1126/science.8378774 · DOI
- 10.1126/science.8397445 · DOI
- SCHINDLER, C, PROTEINS OF TRANSCRIPTION FACTOR ISGF-3 - ONE GENE ENCODES THE 91-KDA AND 84-KDA ISGF-3 PROTEINS THAT ARE ACTIVATED BY INTERFERON-ALPHA, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 89: 7836 (1992).
- 10.1126/science.1496401 · DOI · Paper page
- 10.1126/science.1281555 · DOI
- 10.1126/science.7690989 · DOI · Paper page
- SILVENNOINEN, O, STRUCTURE OF THE MURINE JAK2 PROTEIN-TYROSINE KINASE AND ITS ROLE IN INTERLEUKIN-3 SIGNAL-TRANSDUCTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 8429 (1993).
- STAHL, N, THE ALPHAS, BETAS, AND KINASES OF CYTOKINE RECEPTOR COMPLEXES, CELL 74: 587 (1993). · DOI
- 10.1016/0092-8674(92)90105-L · DOI
- WEGENKA, U.M., ACUTE-PHASE RESPONSE FACTOR, A NUCLEAR FACTOR BINDING TO ACUTE-PHASE RESPONSE ELEMENTS, IS RAPIDLY ACTIVATED BY INTERLEUKIN-6 AT THE POSTTRANSLATIONAL LEVEL, MOLECULAR AND CELLULAR BIOLOGY 13: 276 (1993).
- WILKS, A.F., 2 NOVEL PROTEIN-TYROSINE KINASES, EACH WITH A 2ND PHOSPHOTRANSFERASE-RELATED CATALYTIC DOMAIN, DEFINE A NEW CLASS OF PROTEIN-KINASE, MOLECULAR AND CELLULAR BIOLOGY 11: 2057 (1991).
- WITTHUHN, B.A., JAK2 ASSOCIATES WITH THE ERYTHROPOIETIN RECEPTOR AND IS TYROSINE-PHOSPHORYLATED AND ACTIVATED FOLLOWING STIMULATION WITH ERYTHROPOIETIN, CELL 74: 227 (1993). · DOI
- YOSHIMURA, A, INVITRO PHOSPHORYLATION OF THE ERYTHROPOIETIN RECEPTOR AND AN ASSOCIATED PROTEIN, PP130, MOLECULAR AND CELLULAR BIOLOGY 12: 706 (1992).
- Yuan, J., Molecular and Cellular Biology 14: 1657 (1994).
- Ip, N. Y., Cell 69: 1121 (1992). · DOI
Cited by
Sorted by citations
Items 501–600 of 704
Antagonism between HTRA3 and TGFβ1 Contributes to Metastasis in Non-Small Cell Lung Cancer.
Zhao, J.-Y., Feng, M., Liu, D., Liu, H.-X., Shi, M., Zhang, J., & Qu, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2507 · Cited by 21
“interferons, epidermal growth factor (EGF) and inflammatory factors (IL-5 and IL-6), indicating HtrA3 may also serve a role in inflammatory reaction [36] .”
BackgroundMicroRNA-125b targeted STAT3 to inhibit laryngeal squamous cell carcinoma cell growth and motility
Feng, J., Fan, Y., Qukuerhan, A., Zhang, H., Yong, J., & Hu, B. (2017) · Oncology Letters · doi:10.3892/ol.2017.6155 · Cited by 22
Stat3 signaling regulates embryonic stem cell fate in a dose-dependent manner
Tai, C.-I., Schulze, E. N., & Ying, Q. (2014) · Biology Open · doi:10.1242/bio.20149514 · Cited by 16
Promoting myelin repair and return of function in multiple sclerosis
Zhang, J., Kramer, E. G., Asp, L., Dutta, D. J., Navrazhina, K., Pham, T., Mariani, J. N., Argaw, A. T., Melendez‐Vasquez, C. V., & John, G. R. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.017 · Cited by 21
“Either homo- or heterodimerization triggers the activation of Janus kinase (JAK) tyrosine kinases [20,21], which leads to cytokine- and cell type-specific phosphorylation and nuclear translocation of Stat transcription factors [22].”
BackgroundTargeting Oligodendrocyte Protection and Remyelination in Multiple Sclerosis
Zhang, J., Kramer, E. G., Mahase, S. S., Dutta, D. J., Bonnamain, V., Argaw, A. T., & John, G. R. (2011) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20244 · Cited by 21
“Homo- or heterodimerization of gpl30 triggers the activation of JAK family of cytoplasmic tyrosine kinases [49,50] leading to cytokine- and cell type-specific phosphorylation and nuclear translocation of of Stat transcription factors [51].”
BackgroundThe growth hormone receptor associates with Jak1, Jak2 and Tyk2 in human liver
Hellgren, G., Jansson, J., Carlsson, L. M. S., & Carlsson, B. (1999) · Growth Hormone & IGF Research · doi:10.1054/ghir.1999.0111 · Cited by 19
FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer
Zhou, Y., Ou, L., Xu, J., Yuan, H., Luo, J.-H., Shi, B., Li, X., Yang, S., & Wang, Y. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03933-z · Cited by 20
Cytokines of the LIF/CNTF family and metabolism.
Pasquin, S., Sharma, M., & Gauchat, J. (2016) · Cytokine · doi:10.1016/j.cyto.2015.12.019 · Cited by 20
Kansuinine A and Kansuinine B from Euphorbia kansui L. Inhibit IL-6-induced Stat3 Activation
Chang, J., Lee, S., Park, M.-H., Kim, M., Hudson, B. I., Park, S.-J., Lee, W., & Rho, M. (2010) · Planta Medica · doi:10.1055/s-0030-1249805 · Cited by 20
Neuroprotective effects of cardiotrophin-like cytokine on retinal ganglion cells
Schuettauf, F., Zurakowski, D., Quinto, K., Varde, M., Besch, D., Laties, A., Anderson, R., & Wen, R. (2005) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-005-1152-7 · Cited by 20
“The heterodimerization of gp130 with LIF-R due to ligand binding of CLC leads to the activation of Janus tyrosine kinases (JAK1, JAK2 and TYK2) [31, 35, 49] as well as the transcription factor STAT3 and tyrosine phosphatase SHP2 [27].”
BackgroundRecombinant Human Interleukin-6 Enhances the Immunoglobulin Secretion of a Rabbit–Rabbit Hybridoma
Liguori, M., Hoff-Velk, J., & Ostrow, D. H. (2001) · Hybridoma · doi:10.1089/027245701750293529 · Cited by 20
Braghiroli, L., Silvestrini, B., Sorrentino, C., Grima, J., Mruk, D., & Cheng, C.-Y. (1998) · Biology of Reproduction · doi:10.1095/biolreprod59.1.111 · Cited by 20
Involvement of Stat3 in interleukin‐6‐induced IgM production in a human B‐cell line
Faris, M., Kokot, N., Stahl, N., & Nel, A. E. (1997) · Immunology · doi:10.1111/j.1365-2567.1997.00350.x · Cited by 20
Activating mechanism of CNTF and related cytokines
Inoue, M., Nakayama, C., & Noguchi, H. (1996) · Molecular Neurobiology · doi:10.1007/bf02755588 · Cited by 20
Interleukin 6 in diseases: cause or cure?
Scholz, W. (1996) · Immunopharmacology · doi:10.1016/0162-3109(95)00040-2 · Cited by 20
Rezzonico, R., Ponzio, G., Loubat, A., Lallemand, D., Proudfoot, A. E. J., & Rossi, B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1261 · Cited by 20
Eudesmane-type sesquiterpenoids from Salvia plebeia inhibit IL-6-induced STAT3 activation.
Jang, H.-J., Oh, H., Hwang, J., Kim, M.-H., Lee, S., Jung, K., Kim, Y.-H., Lee, S.-W., & Rho, M. (2016) · Phytochemistry · doi:10.1016/j.phytochem.2016.08.001 · Cited by 19
Matsumiya, T., Imaizumi, T., Itaya, H., Shibata, T., Yoshida, H., Sakaki, H., Kimura, H., & Satoh, K. (2002) · Life Science · doi:10.1016/s0024-3205(02)01560-6 · Cited by 19
The influence of cotinine on interleukin 6 expression in smokers with cervical preneoplasia
Eppel, W., Worda, C., Frigo, P., Manavi, M., & Czerwenka, K. (2000) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2000.0790121105.x · Cited by 19
“In hematopoietic cells IL-6 binds to the subunit of its receptor and triggers the recruitment of gp130, subsequently leading to the activation of the gp130-associated Janus kinases (JAKs) (14, 15).”
BackgroundSH2 domain protein interaction and possibilities for pharmacological intervention.
Beattie, J. (1996) · Cellular Signalling · doi:10.1016/0898-6568(95)02033-0 · Cited by 19
de Souza, P. C., Henning, P., & Lerner, U. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063287 · Cited by 17
“Of all the pathways activated by OSM, the JAK–STAT pathway is considered the main mediator, as well as for other members in the IL-6 family [81].”
BackgroundInterleukin-6 controls recycling and degradation, but not internalization of its receptors
Flynn, C. M., Kespohl, B., Daunke, T., Garbers, Y., Düsterhöft, S., Rose‐John, S., Haybaeck, J., Lokau, J., Aparicio-Siegmund, S., & Garbers, C. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100434 · Cited by 22
“activation of intracellular signaling cascades, most importantly the janus kinase/signal transducer and activator of transcription (Jak/STAT) pathway (5, 6).”
BackgroundST2/MyD88 deficiency protects mice against aGVHD and spares T-regulatory cells
Griesenauer, B., Jiang, H., Yang, J.-F., Zhang, J.-L., Ramadan, A., Egbosiuba, J. C., Campa, K. A., & Paczesny, S. (2019) · Journal of Immunology · doi:10.4049/jimmunol.1800447 · Cited by 18
“Indeed, pSTAT3 Y705 is increased significantly in patient CD4 T cells before onset of aGVHD (69).”
BackgroundInfluentialJAK-STAT signaling regulation of chicken embryonic stem cell differentiation into male germ cells
Zhang, Y., Zhang, L., Zuo, Q., Wang, Y., Zhang, Y., Xu, Q., Li, B., & Chen, G. (2017) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-017-0167-9 · Cited by 18
A New Model for Developmental Neuronal Death and Excitatory/Inhibitory Balance in Hippocampus
Murase, S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8521-8 · Cited by 23
“The activation of gp-130, in turn, activates the protein tyrosine kinase, Janus kinase, which then phosphorylates STAT3 [87, 88].”
BackgroundJiang, K., Chen, Y., & Jarvis, J. N. (2005) · Placenta · doi:10.1016/j.placenta.2005.04.013 · Cited by 16
Activation of the Jak3 pathway and myeloid differentiation
Mangan, J. K., & Reddy, E. P. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190400005320 · Cited by 16
Smola‐Hess, S., de Silva, U. S., Hadaschik, D., & Pfister, H. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-10-2335 · Cited by 18
“After co-transfection with 1 µg of the vector p4321-luc, 1 µg of CMV–β-gal and 1 µg of pCAGGS-Neo-HA-STAT1F or pCAGGS-Neo-HA-STAT3F, respectively, SW756 cells were stimulated with 100 ng\ml IL- 6 in the presence of 500 ng\ml sgp80 as described above.”
BackgroundInfluentialLeukemia inhibitory factor as a mediator of JAK/STAT activation in murine osteoblasts
Lowe, C., Gillespie, G. A. J., & Pike, W. J. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101106 · Cited by 18
4EBP1 senses extracellular glucose deprivation and initiates cell death signaling in lung cancer
Wang, Y., Lei, J., Zhang, S., Wang, X., Jin, J., Liu, Y., Gan, M., Yuan, Y., Sun, L., Li, X., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05466-5 · Cited by 28
Yuan, H.-J., Houck, K. L. L., Tian, Y., Bharadwaj, U., Hull, K., Zhou, Z., Zhu, M.-Z., Wu, X.-P., Tweardy, D., Romo, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143964 · Cited by 17
Rousseau, F., Chevalier, S., Guillet, C., Ravon, E., Diveu, C., Froger, J., Barbier, F., Grimaud, L., & Gascan, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803239200 · Cited by 23
Characterization of the leukemia inhibitory factor receptor in the goldfish (Carassius auratus).
Hanington, P., & Belosevic, M. (2005) · Fish and Shellfish Immunology · doi:10.1016/j.fsi.2004.09.003 · Cited by 17
Identification of a gp130 Cytokine Receptor Critical Site Involved in Oncostatin M Response*
Olivier, C., Auguste, P., Chabbert, M., Lelièvre, E., Chevalier, S., & Gascan, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5648 · Cited by 17
Wang, Y., & Fuller, G. M. (1995) · Gene · doi:10.1016/0378-1119(95)00295-h · Cited by 17
STAT3–CyPA signaling pathway in endothelial cell apoptosis
Xie, Y., Li, X., & Ge, J. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109413 · Cited by 18
Lymphotropic Viruses: Chronic Inflammation and Induction of Cancers
Harhaj, E. W., & Shembade, N. (2020) · Biology · doi:10.3390/biology9110390 · Cited by 18
Rahim, M. M. A., Parsons, B., Price, E. L., Slaine, P. D., Chilvers, B. L., Seaton, G. S., Wight, A. E., Medina-Luna, D., Dey, S., Grandy, S. L., et al. (2020) · Journal of Virology · doi:10.1128/jvi.00165-20 · Cited by 18
“Wild-type (WT) influenza A/Puerto Rico/8/1934(H1N1) (PR8) virus was generated using the 8-plasmid reverse genetic system (60) as previously described (40, 42).”
MethodRuxolitinib induces autophagy in chronic myeloid leukemia cells
Bagca, B., Ozalp, O., Kurt, C., Mutlu, Z., Saydam, G., Gunduz, C., & Avcı, Ç. (2016) · Tumor Biology · doi:10.1007/s13277-015-3947-4 · Cited by 16
“Alterations in JAK/ STAT signaling pathway are related with variety of malignancies including leukemia [19].”
BackgroundCytokine‐Induced Slowing of STAT3 Nuclear Import; Faster Basal Trafficking of the STAT3β Isoform
Ng, I. H. W., Bogoyevitch, M. A., & Jans, D. A. (2014) · Traffic · doi:10.1111/tra.12181 · Cited by 15
Analysis of the STAT3 interactome using in-situ biotinylation and SILAC
Blumert, C., Kalkhof, S., Brocke-Heidrich, K., Kohajda, T., von Bergen�, M., & Horn, F. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.08.021 · Cited by 10
Self-citationHuda, K. A. S. M., Guo, L., Haga, S., Murata, H., Ogino, T., Fukai, M., Yagi, T., Iwagaki, H., Tanaka, N., & Ozaki, M. (2006) · Transplant International · doi:10.1111/j.1432-2277.2006.00285.x · Cited by 14
“Signal transducer and activator of transcription-3 is generally accepted to be located downstream of the IL-6 signal transduction pathway.”
BackgroundInfluentialFunctionally active fusion protein of the novel composite cytokine CLC/soluble CNTF receptor.
Guillet, C., Lelièvre, E., Plun-Favreau, H., Froger, J., Chabbert, M., Hermann, J., de Coignac, A. B., Bonnefoy, J., Gascan, H., Gauchat, J., et al. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02850.x · Cited by 16
Isolation of Two Interleukin‐6 Response Element Binding Proteins from Acute Phase Rat Liversa
Ripperger, J. A., Fritz, S., RICHTER, K., Dreier, B., SCHNEIDER, K., Lochner, K., Marschalek, R., Hocke, G. M., Lottspeich, F., & Fey, G. H. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32330.x · Cited by 16
Ye, Y., Xie, W., Ma, Z., Wang, X.-P., Wen, Y., Li, X., Qi, H., Wu, H., An, J., Jiang, Y., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01846-2 · Cited by 15
Gustafsson, K. U., Jamalpour, M., Trinh, C., Kharas, M. G., & Welsh, M. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-45 · Cited by 14
“Notably, both G-CSF and IL-6 signal via STAT3 activation [34,35].”
Neuroinflammatory Mechanisms in Alzheimer’s Disease Basic and Clinical Research
Rogers, J. (2012) · Progress in Inflammation Research · doi:10.1007/978-3-0348-8350-4 · Cited by 15
van Puijenbroek, A. V., van der Saag, P. T., & Coffer, P. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4576 · Cited by 15
Matsumoto, Y., Handa, S., & Taki, T. (1997) · Development Growth & Differentiation · doi:10.1046/j.1440-169x.1997.t01-4-00006.x · Cited by 13
Kew, J. N. C., & Sofroniew, M. V. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00590-2 · Cited by 14
Emerging Therapeutic Strategies for Overcoming Proteasome Inhibitor Resistance
Dolloff, N. G. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.03.002 · Cited by 20
Heinrich, P., Haan, S., Harris, K., Hermanns, H., Metz, S., Müller-Newen, G., Schaper, F., & Wiesinger, M. Y. (2006) · doi:10.1016/j.biopha.2006.07.058 · Cited by 14
Self-citationLing, P., Smith, R. J., Mueller, C., Mao, Y., & Bistrian, B. R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201000-00029 · Cited by 8
Gernone, A., & Dammacco, F. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1685.x · Cited by 14
“The mechanism implicated in the signal IL-6R transduction for growth and differentiation has not yet been elucidated, but involvement of the jak, btk and tec genes belonging to the nonsrc tyrosine kinase family has been proposed (Lüttichen et al, 1994; Matsuda et al, 1995).”
Methodgp130 signaling pathways: Recent advances and implications for cardiovascular disease.
Hirota, H., Yoshida, K., Taga, T., & Kishimoto, T. (1996) · Trends in cardiovascular medicine · doi:10.1016/1050-1738(96)00037-0 · Cited by 14
Self-citationTippmer, S., Bossenmaier, B., & Häring, H. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00953.x · Cited by 14
Regulation of α2‐Macroglobulin Gene Expression by Interleukin‐6 a
Horn, F., Wegenka, U., Lütticken, C., Yuan, J.-L., Roeb, E., Boers, W., Buschmann, J., & Heinrich, P. C. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44320.x · Cited by 14
Self-citationSchemarova, I. V. (2006) · Current Issues in Molecular Biology · doi:10.21775/cimb.008.027 · Cited by 13
Ge, Q., Wang, Z., Yu, J., Feng, X., Li, J., Zhang, X., Wang, S., Wang, L., & Chen, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-82486-5 · Cited by 15
Zhou, Y., Stevis, P. E., Cao, J., Ehrlich, G. K., Jones, J. L., Rafique, A., Sleeman, M. W., Olson, W. C., & Franklin, M. C. (2024) · Nature Communications · doi:10.1038/s41467-024-54124-1 · Cited by 16
Activins as candidate cholinergic differentiation factors in vivo
Fann, M.-J., & Patterson, P. H. (1995) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(94)00075-e · Cited by 13
Identification of a regulatory domain of the interleukin-6 receptor.
Grube, B., & Cochrane, C. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32062-8 · Cited by 13
Interleukin-6: biologic properties and role in lymphoproliferative disorders.
Seymour, J. F., & Kurzrock, R. (1996) · Cancer treatment and research · doi:10.1007/978-1-4613-1261-1_9 · Cited by 13
Synthesis of thienopyrimidine derivatives as inhibitors of STAT3 activation induced by IL-6.
Jang, H.-J., Kim, S. M., Rho, M., Lee, S.-W., & Song, Y.-H. (2019) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1811.11046 · Cited by 12
“Therefore, the inhibition of IL-6-induced activation of STAT3 could be a good tool for screening effective therapeutic materials as well as target drugs for the treatment of diseases related to IL-6, including rheumatoid arthritis, atherosclerosis, diabetes, cancer and multiple myeloma [15].”
MethodAssociation between STAT3 polymorphisms and cancer risk: a meta-analysis
Yan, R.-C., Lin, F.-S., Hu, C., & Tong, S.-L. (2015) · Zeitschrift für Induktive Abstammungs- und Vererbungslehre · doi:10.1007/s00438-015-1074-y · Cited by 12
“STAT3, a member of a transcription factor family, was first identified in 1994 as an IL-6-activated acute-phase response factor (APRF) (Lutticken et al. 1994).”
BackgroundHuang, Y., Hung, W., Kang, W., Chen, W.-T., & Chai, C. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.06.009 · Cited by 12
Response to IL-6 of HPV-18 Cervical Carcinoma Cell Lines
Bauknecht, T., Randelzhofer, B., Schmitt, B., Bán, Z., Hernando, J. J., & Bauknecht, T. (1999) · Virology · doi:10.1006/viro.1999.9722 · Cited by 11
Christ, B., Nath, A., & Jungermann, K. (1997) · Hepatology · doi:10.1002/hep.510260110 · Cited by 12
Inhibition of HIV Type 1 Tat-Mediated trans-Activation by Oncostatin M in HLtat Cells
Esté, J., Witvrouw, M., Tu, J., Desmyter, J., Clercq, E. D., & Vandamme, A. (1995) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1995.11.1355 · Cited by 12
IL-6 Blockers in Systemic Onset Juvenile Idiopathic Arthritis
Barone, P., Pignataro, R., Garozzo, M. T., & Leonardi, S. (2015) · Immunotherapy · doi:10.2217/imt.15.104 · Cited by 12
Nuclear Signaling Pathways and Targeting Transcription in Cancer
Kumar, R. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-8039-6 · Cited by 17
Intragenic regulation of SOCS3 isoforms
Klepsch, O., Namer, L. S., Köhler, N., Kaempfer, R. O. R., Dittrich, A., & Schaper, F. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0379-6 · Cited by 11
“and translocate into the nucleus where they activate transcription of IL-6-inducible genes, such as acute-phase genes [5, 6].”
BackgroundXu, L., Ji, J.-J., Le, W., Xu, Y. S., Dou, D., Pan, J., Jiao, Y., Zhong, T., Wu, D., Wang, Y., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv911 · Cited by 27
“STAT3, known as the acute-phase response element, was first described in hepatocytes (1,2) and can be activated by the interleukin-6 (IL-6) cytokine family, type I interferon and epidermal growth factor (EGF) (3,4).”
BackgroundCharacterization of receptors for ciliary neurotrophic factor on rat hippocampal astrocytes.
Alderson, R., Pearsall, D., Lindsay, R., & Wong, V. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01273-6 · Cited by 11
Takeda, T., Kurachi, H., Yamamoto, T., Homma, H., Adachi, K., Morishige, K., Miyake, A., & Murata, Y. (1997) · Endocrinology · doi:10.1210/endo.138.7.5280 · Cited by 12
“IL-6 also uses the gp130-JAK-STAT (STAT3) signal transduction pathway and activates the APRE (14, 15).”
BackgroundMethodInoue, M., Minami, M., Matsumoto, M., Kishimoto, T., & Akira, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9550 · Cited by 12
Self-citationMOLECULAR BIOLOGY OF CYTOKINES IN ALLERGIC DISEASES AND ASTHMA
Fishman, S., Hobbs, K., & Borish, L. (1996) · The Radiologic clinics of North America · doi:10.1016/s0889-8561(05)70263-0 · Cited by 11
Biosynthetic and glycosylation events of the IL‐6 receptor β‐Subunit, gp130
Wang, Y., & Fuller, G. M. (1995) · doi:10.1002/jcb.240570405 · Cited by 11
Dai, K.-J., Chen, L., Liu, J., Ding, Y., Gu, C., & Lu, X.-J. (2021) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/130599 · Cited by 10
Zhu, B., Zhu, Y., Lou, J., Ke, J., Zhang, Y., Li, J., Gong, Y., Yang, Y., Tian, J., Peng, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11607 · Cited by 13
“STAT3, a member of a transcription factor family, was first identified in 1994 as an IL-6-activated acute-phase response factor (APRF) [38].”
BackgroundZhuang, Q., Li, J., Chen, Y., Lin, J., LAI, F., Chen, X., LIN, X., & Peng, J. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4086 · Cited by 11
“Apoptotic cell death is recognizable by cellular morphological characteristics, including membrane blebbing and chromatin condensation (18).”
Askvig, J. M., Lo, D. Y., Sudbeck, A., Behm, K. E., Leiphon, L. J., & Watt, J. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.10.023 · Cited by 10
“, 1993), is phosphorylated by Jak molecules (Lutticken et al., 1994).”
BackgroundResultPeng, Y., Zhou, B., Wang, Y.-Y., Chen, Y., Li, H., Song, Y., Zhang, L., & Rao, L. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1057-1 · Cited by 10
“The Janus kinase-signal transducers and activators of transcription (JAK-STAT) pathway transmit signals of a wide range of cytokines, growth factors, and hormones and it has been shown to mediate hypertrophic and cytoprotective effects of gp130 activation in cardiomyocytes [12–18].”
BackgroundInterleukin-11, an IL-6-like cytokine
Hook, C., & Kuprash, D. V. (2011) · Molecular Biology · doi:10.1134/s0026893311010055 · Cited by 11
Co-activator SRC-1 is dispensable for transcriptional control by STAT3.
Cvijic, H., Bauer, K., Löffler, D., Pfeifer, G., Blumert, C., Kretzschmar, A., Henze, C., Brocke-Heidrich, K., & Horn, F. (2009) · Biochemical Journal · doi:10.1042/bj20081989 · Cited by 10
Self-citationCell swelling activates STAT1 and STAT3 proteins in cultured rat hepatocytes
Meisse, D., Dusanter-Fourt, I., Husson, A., & Lavoinne, A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01643-9 · Cited by 10
Simar-Blanchet, A.-E., Paul, C., Mercier, L., & le Cam, A. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00638.x · Cited by 10
Cytokine regulation of HIV-1 LTR transactivation in human hepatocellular carcinoma cell lines.
Hsu, M.-L., Chen, S.-W., Lin, K.-H., Liao, S., & Chang, K. S. S. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03820-m · Cited by 10
Termination and modulation of IL-6-type cytokine signaling.
Heinrich, P. C., Bode, J. G., Decker, M., Graeve, L., Martens, A. S., Müller-Newen, G., Pflanz, S., Schaper, F., & Schmitz, J. (2001) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0685-0_20 · Cited by 10
Self-citationCentral TYK2 inhibition identifies TYK2 as a key neuroimmune modulator
Molitor, T. P., Hayashi, G., Lin, M.-Y., Dunn, C. J., Peterson, N. G., Poston, R. G., Kurnellas, M., Traver, D., Patel, S., Akgungor, Z., et al. (2025) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2422172122 · Cited by 9
“Compound selectivity profiles against other JAK family members were measured via IL - 6 - induced pSTAT3 (17, 18) and GM - CSF - induced pSTAT5 abundance (19, 20); IC 50 s summarized in Table 1.”
Fasouli, E. S., & Katsantoni, E. Z. (2024) · FEBS Letters · doi:10.1002/1873-3468.14985 · Cited by 12
The acetylation of STAT3 at K685 attenuates NPM-ALK-induced tumorigenesis
Korai, A., Lin, X., Tago, K., & Funakoshi‐Tago, M. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110985 · Cited by 8
Dynamic Changes in pStat3 Are Involved in Meiotic Spindle Assembly in Mouse Oocytes
Haraguchi, S., Ikeda, M., Akagi, S., & Hirao, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041220 · Cited by 9
Pro-inflammatory cytokines in patients with chronic kidney disease: interleukin-6 in focus
Murkamilov, I., Aitbae, K. A., Fomin, V., Murkamilova, Z., Sabirov, I., Rayimzhanov, Z., Redzhapova, N. A., & Yusupov, F. (2019) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2019-9-6-428-433 · Cited by 9
Silencing of CXCL12 performs a protective effect on C5b-9-induced injury in podocytes
Sha, W.-G., Shen, L., Zhou, L., Xu, D.-Y., Yang, J., & Lu, G.-Y. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1799-8 · Cited by 9
Interaction of Notch and gp130 Signaling in the Maintenance of Neural Stem and Progenitor Cells
Kotasová, H., Procházková, J., & Pachernı́k, J. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9996-6 · Cited by 9
Yagi, T., Yoshioka, H., Wakai, T., Kato, T., Horikoshi, T., & Kinouchi, H. (2011) · Brain Research · doi:10.1016/j.brainres.2011.08.076 · Cited by 8
Alkamides from Piper longum and Piper nigrum as Inhibitors of IL-6 action
Lee, S.-W., Kim, M., Park, M.-H., Park, S.-J., Lee, W., Chang, J., & Rho, M. (2010) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2010.31.04.921 · Cited by 9
Transactivation of gp130 in Myeloma Cells 1
French, J., Walters, D. K., & Jelinek, D. (2003) · Journal of Immunology · doi:10.4049/jimmunol.170.7.3717 · Cited by 9
EXPRESSION AND REGULATION OF GP130 MESSENGER RIBONUCLEIC ACID IN CULTURED IMMATURE RAT SEROLI CELLS
Fujisawa, M., Okuda, Y., Fujioka, H., & Kamidono, S. (2002) · doi:10.1081/erc-120004532 · Cited by 9
“Binding of these cytokines to their specific cell-surface receptors results in tyrosine phosphorylation of gp130 by members of the Janus kinase (JAK) family of tyrosine kinases (3) and subsequent tyrosine phosphorylation of several downstream signaling molecules including members of the signal transducers and activato…”
Background
Metadata
- Authors
- Lütticken, C., Wegenka, U. M., Yuan, J., Buschmann, J., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F., Yasukawa, K., Taga, T., Kishimoto, T., Barbieri, G., Pellegrini, S., Sendtner, M., Heinrich, P. C., & Horn, F.
- Affiliations
- RWTH Aachen University (DE)
- ORCID
- Venue
- Science
- Published
- 1994-01-07
- Volume
- 263
- Issue
- 5143
- Pages
- 89-92
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1999028040
- Cited by
- 814
- References
- 0
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 11 · 2023: 5 · 2022: 7 · 2021: 13 · 2020: 10 · 2019: 14 · 2018: 14 · 2017: 17 · 2016: 17 · 2015: 23 · 2014: 15 · 2013: 15 · 2012: 20
- FWCI
- 38.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- JAK1, gp130, IL-6 signaling, cytokine-receptor complex, tyrosine phosphorylation, transcription factor activation, leukemia inhibitory factor, oncostatin M, interleukin-11, ciliary neurotrophic factor, signal transduction
- MeSH terms
- Base Sequence, DNA-Binding Proteins, Humans, Interferon-gamma, Membrane Glycoproteins, Molecular Sequence Data, Phosphorylation, Protein-Tyrosine Kinases, Transcription Factors, Tumor Cells, Cultured, Tyrosine, Signal Transduction, Trans-Activators, Antigens, CD, Interleukin-6, Cytokines, STAT1 Transcription Factor, STAT3 Transcription Factor, Cytokine Receptor gp130, Interferon-Stimulated Gene Factor 3, Interferon-Stimulated Gene Factor 3, gamma Subunit, Janus Kinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review